272 related articles for article (PubMed ID: 22997207)
21. Peripheral arterial disease in patients with chronic obstructive pulmonary disease.
Pecci R; De La Fuente Aguado J; Sanjurjo Rivo AB; Sanchez Conde P; Corbacho Abelaira M
Int Angiol; 2012 Oct; 31(5):444-53. PubMed ID: 22990507
[TBL] [Abstract][Full Text] [Related]
22. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.
Lindberg A; Lundbäck B
Clin Respir J; 2008 Oct; 2 Suppl 1():64-71. PubMed ID: 20298352
[TBL] [Abstract][Full Text] [Related]
23. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
24. Patients with chronic obstructive pulmonary disease have shorter survival but superior endovascular outcomes after endovascular aneurysm repair.
Qureshi MA; Greenberg RK; Mastracci TM; Eagleton MJ; Hernandez AV
J Vasc Surg; 2012 Oct; 56(4):911-9.e2. PubMed ID: 23026421
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic and treatment of chronic obstructive pulmonary disease based on GOLD statement 2011].
Barczyk A; Pierzchała W
Pol Merkur Lekarski; 2012 Oct; 33(196):187-92. PubMed ID: 23272604
[TBL] [Abstract][Full Text] [Related]
26. Lung function decline and outcomes in an adult population.
Mannino DM; Reichert MM; Davis KJ
Am J Respir Crit Care Med; 2006 May; 173(9):985-90. PubMed ID: 16439715
[TBL] [Abstract][Full Text] [Related]
27. Preoperative spirometry results as a determinant for long-term mortality after EVAR for AAA.
Ohrlander T; Dencker M; Acosta S
Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):43-7. PubMed ID: 22051733
[TBL] [Abstract][Full Text] [Related]
28. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
[TBL] [Abstract][Full Text] [Related]
29. Socioeconomic status and prognosis of COPD in Denmark.
Lange P; Marott JL; Vestbo J; Ingebrigtsen TS; Nordestgaard BG
COPD; 2014 Aug; 11(4):431-7. PubMed ID: 24568315
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic goals and outcome measurements in COPD patients].
Morr H
Med Klin (Munich); 2006 Apr; 101(4):279-82. PubMed ID: 16607483
[TBL] [Abstract][Full Text] [Related]
31. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
32. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
33. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
34. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
35. Relationship of the 2011 Global Initiative for Chronic Obstructive Lung Disease strategy to clinically relevant outcomes in individuals with α1-antitrypsin deficiency.
Pillai AP; Turner AM; Stockley RA
Ann Am Thorac Soc; 2014 Jul; 11(6):859-64. PubMed ID: 24950156
[TBL] [Abstract][Full Text] [Related]
36. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
37. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
[TBL] [Abstract][Full Text] [Related]
38. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Bhowmik A; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 2000 May; 161(5):1608-13. PubMed ID: 10806163
[TBL] [Abstract][Full Text] [Related]
39. The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period.
Ting SC; Crooks SW; South G
J Epidemiol Community Health; 2011 Feb; 65(2):157-9. PubMed ID: 19996358
[TBL] [Abstract][Full Text] [Related]
40. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.
Tantucci C; Donati P; Nicosia F; Bertella E; Redolfi S; De Vecchi M; Corda L; Grassi V; Zulli R
Respir Med; 2008 Apr; 102(4):613-9. PubMed ID: 18083020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
